Application 077654

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CITALOPRAM HYDROBROMIDE	CITALOPRAM HYDROBROMIDE	TABLET;ORAL	EQ 10MG BASE	No	No
002	CITALOPRAM HYDROBROMIDE	CITALOPRAM HYDROBROMIDE	TABLET;ORAL	EQ 20MG BASE	No	No
003	CITALOPRAM HYDROBROMIDE	CITALOPRAM HYDROBROMIDE	TABLET;ORAL	EQ 40MG BASE	No	No

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
68462-113	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Generics Inc., USA	ANDA	Current
68462-114	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Generics Inc., USA	ANDA	Current
68462-115	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Generics Inc., USA	ANDA	Current
72657-109	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Therapeutics Inc., USA	ANDA	Current
72657-109	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Therapeutics Inc., USA	ANDA	Current
72657-110	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Therapeutics Inc., USA	ANDA	Current
72657-110	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Therapeutics Inc., USA	ANDA	Current
72657-111	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Therapeutics Inc., USA	ANDA	Current
72657-111	Citalopram Hydrobromide	Citalopram Hydrobromide	Glenmark Therapeutics Inc., USA	ANDA	Current

Document, Submission type, Date table
Document	Submission type	Date
23880	ORIG	2009-03-19